Atovaquone Compared with Dapsone for the Prevention of Pneumocystis carinii Pneumonia in Patients with HIV Infection Who Cannot Tolerate Trimethoprim, Sulfonamides, or Both
The prevention of Pneumocystis carinii pneumonia has had a substantial influence on the course of human immunodeficiency virus (HIV) disease. 1 , 2 Although trimethoprim–sulfamethoxazole is the treatment of choice for prophylaxis against P. carinii pneumonia, intolerance often limits its use and mak...
Saved in:
Published in: | The New England journal of medicine Vol. 339; no. 26; pp. 1889 - 1895 |
---|---|
Main Authors: | , , , , , , , , , , , |
Format: | Journal Article |
Language: | English |
Published: |
Boston, MA
Massachusetts Medical Society
24-12-1998
|
Subjects: | |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The prevention of
Pneumocystis carinii
pneumonia has had a substantial influence on the course of human immunodeficiency virus (HIV) disease.
1
,
2
Although trimethoprim–sulfamethoxazole is the treatment of choice for prophylaxis against
P. carinii
pneumonia, intolerance often limits its use and makes it necessary to use alternative regimens.
3
Dapsone, alone or in combination with pyrimethamine, is a commonly recommended prophylactic regimen for
P. carinii
pneumonia in patients who cannot tolerate trimethoprim–sulfamethoxazole.
4
Dapsone plus pyrimethamine has been shown to be superior to aerosolized pentamidine for the prevention of toxoplasmosis.
5
However, dapsone has limitations: it is less effective than trimethoprim–sulfamethoxazole for the prevention . . . |
---|---|
Bibliography: | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
ISSN: | 0028-4793 1533-4406 |
DOI: | 10.1056/NEJM199812243392604 |